Literature DB >> 34321129

Comparing Stop Signal Reaction Times in Alzheimer's and Parkinson's Disease.

Simin Rahman1, Ummatul Siddique1, Supriyo Choudhury1, Nazrul Islam2, Akash Roy1, Purba Basu1, Sidharth Shankar Anand1, Mohammad Ariful Islam2, Mohammad Selim Shahi2, Abu Nayeem2, Md Tauhidul Islam Chowdhury2, Mohammad Shah Jahirul Hoque Chowdhury2, John-Paul Taylor3, Mark R Baker3,4, Stuart N Baker3, Hrishikesh Kumar1.   

Abstract

BACKGROUND: To investigate the relative contributions of cerebral cortex and basal ganglia to movement stopping, we tested the optimum combination Stop Signal Reaction Time (ocSSRT) and median visual reaction time (RT) in patients with Alzheimer's disease (AD) and Parkinson's disease (PD) and compared values with data from healthy controls.
METHODS: Thirty-five PD patients, 22 AD patients, and 29 healthy controls were recruited to this study. RT and ocSSRT were measured using a hand-held battery-operated electronic box through a stop signal paradigm. RESULT: The mean ocSSRT was found to be 309 ms, 368 ms, and 265 ms in AD, PD, and healthy controls, respectively, and significantly prolonged in PD compared to healthy controls (p = 0.001). The ocSSRT but not RT could separate AD from PD patients (p = 0.022).
CONCLUSION: Our data suggest that subcortical networks encompassing dopaminergic pathways in the basal ganglia play a more important role than cortical networks in movement-stopping. Combining ocSSRT with other putative indices or biomarkers of AD (and other dementias) could increase the accuracy of early diagnosis.

Entities:  

Keywords:  Alzheimer’s disease; Parkinson’s disease; Response inhibition; Stop Signal Reaction Time

Mesh:

Substances:

Year:  2021        PMID: 34321129     DOI: 10.1017/cjn.2021.184

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.915


  1 in total

1.  Exploring stop signal reaction time over two sessions of the anticipatory response inhibition task.

Authors:  Alison Hall; Ned Jenkinson; Hayley J MacDonald
Journal:  Exp Brain Res       Date:  2022-10-14       Impact factor: 2.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.